BIOTECH: BioNTech Plans to Establish a Local Research Facility
The recent acquisition of San Diego’s MabVax has been a long time coming. MabVax sold its cancer drug assets and its lab equipment to German company BioNTech, it was announced earlier this month.
San Diego’s Trovagene will partner with Nektar Therapeutics to explore combining their two drug candidates to treat metastatic colon cancer.
Locana, a San Diego biotech that repurposed the gene-editing system CRISPR, has raised a $55 million series A round.
San Diego’s Reneo Pharmaceuticals raised a $50 million Series A round to tackle metabolism and energy disorders.
HEALTH: Arm of Moores Cancer Center Holds Annual Symposium
A department at UC San Diego Health’s Moores Cancer Center is known for putting on a symposium to translate groundbreaking oncology discoveries into therapeutics.
PHARMA: Acquisitions Part of CRO Consolidation Trend Locally, Nationwide
WuXi AppTec is making moves in San Diego. The Chinese pharmaceutical company earlier this month bought San Diego-based Pharmapace.
HEALTH: Hospitals Grapple With Use, Costs and Concerns
Rady Children’s Hospital holds a world record for fastest genomic diagnosis. Instrumental in the feat: artificial intelligence.
M&A: Co. Will Operate as Armata Pharmaceuticals
Two companies, new name. San Diego-based AmpliPhi Biosciences and Marina del Rey’s C3J Therapeutics have merged, operating as Armata Pharmaceuticals, focused on antibiotic-resistant infections.
Carlsbad’s Ra Medical Systems on May 16 sued Strata Skin Sciences and its board chair. The lawsuit alleges a campaign of false and misleading statements to financial partners before, during and after Ra Medical’s initial public offering.
BIOTECH: Co. Gets Licensing Fee From Argenx
San Diego-based Halozyme reported higher revenue and net income in first quarter results, thanks to the company’s platform technology. Looking forward, the company is heading for an inflection point.